This formulation combines Bisoprolol Fumarate 5 mg and Dapagliflozin 10 mg, providing an effective dual approach for managing hypertension and type 2 diabetes mellitus. Bisoprolol Fumarate is a cardio-selective beta-blocker that helps reduce blood pressure, control heart rate, and decrease the risk of heart-related complications. Dapagliflozin belongs to the SGLT2 inhibitor class, which helps lower blood glucose levels by increasing urinary glucose excretion, aiding in better glycemic control. Together, these ingredients support heart and kidney health, improve cardiovascular outcomes, and help manage blood sugar levels efficiently. The formulation is designed for once-daily oral administration, ensuring convenience and better patient adherence.
